Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
A case that describes how treatment decisions for a seriously ill baby should consider the advice and recommendations of the medical team as well as the parental preferences for the child's care.